The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Metformin restores endothelial function in aorta of diabetic rats
Open accessAbstract
BACKGROUND AND PURPOSE: The effects of metformin, an antidiabetic agent that improves insulin sensitivity, on endothelial function have not been fully elucidated. This study was designed to assess the effect of metformin on impaired endothelial function, oxidative stress, inflammation and advanced glycation end products formation in type 2 diabetes mellitus. EXPERIMENTAL APPROACH: Goto‐Kakizaki (GK) rats, an animal model of nonobese type 2 diabetes, fed with normal and high‐fat diet during 4 months were treated with metformin for 4 weeks before evaluation. Systemic oxidative stress, endothelial function, insulin resistance, nitric oxide (NO) bioavailability, glycation and vascular oxidative stress were determined in the aortic rings of the different groups. A pro‐inflammatory biomarker the chemokine CCL2 (monocyte chemoattractant protein‐1) was also evaluated. KEY RESULTS: High‐fat fed GK rats with hyperlipidaemia showed increased vascular and systemic oxidative stress and impaired endothelial‐dependent vasodilatation. Metformin treatment significantly improved glycation, oxidative stress, CCL2 levels, NO bioavailability and insulin resistance and normalized endothelial function in aorta. CONCLUSION AND IMPLICATIONS: Metformin restores endothelial function and significantly improves NO bioavailability, glycation and oxidative stress in normal and high‐fat fed GK rats. This supports the concept of the central role of metformin as a first‐line therapeutic to treat diabetic patients in order to protect against endothelial dysfunction associated with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Endothelial dysfunction in diabetes
De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703393 · Cited by 1,165
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
Metformin therapy and clinical uses
Scarpello, J. H., & Howlett, H. C. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.027 · Cited by 318 · cited 4×
“Several studies have reported the inhibitory effect of metformin on oxidative stress under various conditions: in vitro in either hyperglycaemic or hyperlipidaemic environments as well as in vivo (Gargiulo et al., 2002; Bellin et al., 2006; Faure et al., 1999; Matsumoto et al., 2008; Scarpello and Howlett, 2008).”
BackgroundInfluentialFaure, P., Rossini, E., Wiernsperger, N., Richard, M. J., Favier, A., & Halimi, S. (1999) · Diabetes · doi:10.2337/diabetes.48.2.353 · Cited by 166 · cited 2×
“Several studies have reported the inhibitory effect of metformin on oxidative stress under various conditions: in vitro in either hyperglycaemic or hyperlipidaemic environments as well as in vivo (Gargiulo et al., 2002; Bellin et al., 2006; Faure et al., 1999; Matsumoto et al., 2008; Scarpello and Howlett, 2008).”
BackgroundCaballero, A. E., Delgado, A., Aguilar-Salinas, C. A., Herrera, A. N., Castillo, J. L., Cabrera, T., Gomez-Perez, F. J., & Rull, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0019 · Cited by 151 · cited 2×
“Clinical studies further suggest that metformin may alter inflammation as determined by decreased inflammatory markers in plasma, including soluble intercellular adhesion molecule, vascular cell adhesion molecule-1, nuclear factor k-B and C-reactive protein in some cases of polycystic ovary syndrome, indicating modula…”
BackgroundRösen, P., & Wiernsperger, N. F. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.623 · Cited by 102
Cited by
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Self-citationMetformin and inflammation: its potential Beyond glucose-lowering effect
Saisho, Y. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150316124019 · Cited by 450
Brownfoot, F. C., Hastie, R., Hannan, N. J., Cannon, P., Tuohey, L., Parry, L. J., Senadheera, S., Illanes, S. E., Kaitu’u-Lino, T. J., & Tong, S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.019 · Cited by 222
Metadata
- Authors
- Sena, C. M., Matafome, P., Louro, T., Nunes, E., Fernandes, R., & Seiça, R. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-04-18
- Volume
- 163
- Issue
- 2
- Pages
- 424-437
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1595719516
- Cited by
- 170
- References
- 12
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin restores endothelial function in aorta of diabetic rats. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01230.x
- The paper
- Sena, C. M., Matafome, P., Louro, T., Nunes, E., Fernandes, R., & Seiça, R. M. (2011). Metformin restores endothelial function in aorta of diabetic rats. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01230.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.